UCLA HIV Prevention and Treatment Trials
UCLA AIDS Prevention and Treatment Clinical Trials Unit
Testing new prevention, treatment, and vaccine approaches for adults living with or at risk for HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11456949 on NIH RePORTER |
What this research studies
This program runs clinical trials of medicines, prevention methods (such as PrEP), and vaccines aimed at reducing HIV infections and improving care for people with HIV. You would join studies at UCLA clinics and partner sites in Los Angeles and in South America, where study teams check your health, collect samples, and monitor outcomes over time. The unit brings together experienced clinicians and researchers to enroll diverse participants across age groups and communities. Trials include both people living with HIV who need treatment advances and people at risk who want new prevention options.
Who could benefit from this research
Good fit: Adults living with HIV or adults at risk of HIV who can attend a participating clinic and agree to study visits and procedures are the most likely candidates.
Not a fit: People not living with or at risk for HIV, children when studies are restricted to adults, or those unable to travel to participating sites are unlikely to be eligible or directly benefit.
Why it matters
Potential benefit: If successful, the research could produce better treatments, stronger prevention tools, or a vaccine that lowers new HIV infections and improves patient care.
How similar studies have performed: Earlier trials have produced highly effective antiretroviral treatments and prevention tools like PrEP, while HIV vaccine efforts have shown mixed results and continue to be actively studied.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Landovitz, Raphael J — University of California Los Angeles
- Study coordinator: Landovitz, Raphael J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.